First Light Diagnostics | WebDisclosure

Switch to English

10651	Sociétés
226542	Mots-clés
155028	Articles
119935	Communiqués

Accueil
Sociétés
First Light Diagnostics

COMMUNIQUÉ DE PRESSE

publié le 05/12/2023 à 16:00, il y a 2 années 6 mois

First Light Diagnostics Receives FDA Clearance for its Rapid B. anthracis Toxin Test on the MultiPath Analyzer
First Light Diagnostics receives FDA clearance for its SensiTox B. anthracis Toxin Test, a 20-minute, sensitive immunofluorescence assay for early detection of inhalation anthrax, marking a significant advancement in biodefense and public health

FDA Clearance First Light Diagnostics SensiTox B. Anthracis Toxin Test Inhalation Anthrax Biodefense

Les Echos

Publié le 26/06/2026 à 17:45, il y a 13 heures 50 minutes

Combined General Meeting, June 25, 2026
Publié le 26/06/2026 à 17:45, il y a 13 heures 50 minutes

Assemblée générale mixte du 25 juin 2026
Publié le 26/06/2026 à 17:45, il y a 13 heures 50 minutes

Descriptif du programme de rachat d'actions
Publié le 26/06/2026 à 14:44, il y a 16 heures 50 minutes

Safran information
Publié le 26/06/2026 à 14:44, il y a 16 heures 50 minutes

Information Safran

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 27/06/2026 à 01:40, il y a 5 heures 55 minutes

Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Publié le 27/06/2026 à 00:00, il y a 7 heures 35 minutes

Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Publié le 26/06/2026 à 23:00, il y a 8 heures 35 minutes

Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Publié le 26/06/2026 à 22:50, il y a 8 heures 45 minutes

Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Publié le 26/06/2026 à 22:15, il y a 9 heures 20 minutes

Revive Therapeutics Announces Proposed Private Placement

Voir tout ACCESSWIRE

EQS Group

Publié le 27/06/2026 à 00:05, il y a 7 heures 29 minutes

EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Publié le 27/06/2026 à 00:04, il y a 7 heures 30 minutes

Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Publié le 26/06/2026 à 23:36, il y a 7 heures 59 minutes

Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Publié le 26/06/2026 à 23:36, il y a 7 heures 59 minutes

EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Publié le 26/06/2026 à 23:27, il y a 8 heures 7 minutes

EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE